Clarius Group LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$723K Sell
1,625
-193
-11% -$85.9K 0.04% 188
2025
Q1
$881K Buy
1,818
+440
+32% +$213K 0.06% 158
2024
Q4
$555K Sell
1,378
-130
-9% -$52.4K 0.04% 203
2024
Q3
$700K Sell
1,508
-48
-3% -$22.3K 0.05% 162
2024
Q2
$729K Sell
1,556
-94
-6% -$44.1K 0.05% 158
2024
Q1
$690K Sell
1,650
-308
-16% -$129K 0.05% 173
2023
Q4
$797K Sell
1,958
-127
-6% -$51.7K 0.07% 157
2023
Q3
$725K Sell
2,085
-415
-17% -$144K 0.07% 156
2023
Q2
$880K Buy
2,500
+48
+2% +$16.9K 0.07% 153
2023
Q1
$773K Sell
2,452
-110
-4% -$34.7K 0.07% 169
2022
Q4
$740K Buy
2,562
+62
+2% +$17.9K 0.07% 175
2022
Q3
$724K Buy
2,500
+64
+3% +$18.5K 0.07% 161
2022
Q2
$686K Buy
2,436
+316
+15% +$89K 0.07% 174
2022
Q1
$466K Hold
2,120
0.04% 254
2021
Q4
$466K Sell
2,120
-76
-3% -$16.7K 0.04% 254
2021
Q3
$398K Buy
2,196
+85
+4% +$15.4K 0.04% 260
2021
Q2
$426K Sell
2,111
-23
-1% -$4.64K 0.04% 243
2021
Q1
$459K Buy
2,134
+320
+18% +$68.8K 0.05% 207
2020
Q4
$429K Buy
1,814
+132
+8% +$31.2K 0.05% 194
2020
Q3
$458K Sell
1,682
-27
-2% -$7.35K 0.06% 149
2020
Q2
$496K Buy
1,709
+155
+10% +$45K 0.07% 136
2020
Q1
$370K Buy
1,554
+103
+7% +$24.5K 0.07% 148
2019
Q4
$340K Buy
1,451
+43
+3% +$10.1K 0.05% 185
2019
Q3
$239K Buy
+1,408
New +$239K 0.04% 238
2019
Q2
Sell
-1,152
Closed -$212K 270
2019
Q1
$212K Buy
+1,152
New +$212K 0.05% 196